$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Osmotic system with distribution zone for dispensing beneficial agent 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61M-007/00
출원번호 US-0953906 (1978-10-23)
발명자 / 주소
  • Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA)
출원인 / 주소
  • Alza Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 418  인용 특허 : 1

초록

An osmotic system is disclosed for dispensing a beneficial agent. The system comprises (1) a first wall of a semipermeable material that surrounds a compartment containing a drug formulation, and has a passageway through the wall for releasing agent from the compartment, (2) a second wall positioned

대표청구항

A laminate useful for manufacturing a device for dispensing a beneficial agent to a fluid environment of use, said laminate comprising a first lamina formed of a member selected from the group consisting of cellulose acylate, cellulose diacylate and cellulose triacylate, a third lamina spaced distan

이 특허에 인용된 특허 (1)

  1. Hudgin Donald Edward (Princeton Junction NJ) Blair Edgar Allan (Cranbury NJ), Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles.

이 특허를 인용한 특허 (418)

  1. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, 8a,14-dihydroxy-7,8-dihydrocodeinone.
  2. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  3. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  4. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  5. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  6. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  7. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  8. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  9. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  10. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  11. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  12. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  13. Bonuttti, Peter M, Acoustic therapy device.
  14. Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use.
  15. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  16. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  17. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  18. Zerangue,Noa; Jandeleit,Bernd; Li,Yunxiao; Gallop,Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  19. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  20. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  21. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  22. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  23. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  24. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  25. Gallop,Mark A., Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use.
  26. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Los Altos CA), Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container.
  27. Gallop, Mark; Cundy, Kenneth C.; Scheuerman, Randall A.; Barrett, Ronald W.; Zerangue, Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  28. Gallop,Mark; Cundy,Kenneth C.; Scheuerman,Randall A.; Barrett,Ronald W.; Zerangue,Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  29. Edgren David E. (El Granada CA) Theeuwes Felix (Los Altos CA), Annealed coats.
  30. Orban, III, Joseph P.; Nolan, Timothy, Annular support structures.
  31. Orban, III, Joseph P.; Nolan, Timothy, Annular support structures.
  32. Orban, III, Joseph P.; Nolan, Timothy, Annular support structures.
  33. Orban, III, Joseph P.; Nolan, Timothy, Annular support structures.
  34. Orban, III, Joseph P.; Nolan, Timothy, Annular support structures.
  35. Ayer Atul Devdatt (Palo Alto CA) Ridzon Dana (San Francisco CA), Antidepressive therapy.
  36. Edgren David E. (El Granada CA) Theeuwes Felix (Los Altos CA), Aqueous based pharmaceutical coating composition for dosage forms.
  37. Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA), Aqueous emulsion for pharmaceutical dosage form.
  38. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  39. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  40. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  41. Blaskovich, Phillip D.; Ohri, Rachit; Bennett, Steven L., Biodegradable osmotic pump implant for drug delivery.
  42. Blaskovich, Phillip; Ohri, Rachit; Bennett, Steven, Biodegradable osmotic pump implant for drug delivery.
  43. Xiang,Jia Ning; Gallop,Mark A.; Cundy,Kenneth C.; Li,Jianhua; Xu,Feng; Zhou,Cindy X.; Bhat,Laxminarayan, Carbidopa prodrugs and derivatives, and compositions and uses thereof.
  44. Chang, James N.; Hughes, Patrick M.; Devries, Gerald W., Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems.
  45. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  46. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  47. Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA), Colon delivery system.
  48. Von Coburg, Yvonne; Reimer, Karen; Oksche, Alexander; Holzer, Peter, Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation.
  49. Magruder Paul R. (Palo Alto CA) Barclay Brian (Menlo Park CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA), Composition comprising a therapeutic agent and a modulating agent.
  50. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Composition comprising drug, HPC, HPMC and PEO.
  51. Hughes, Patrick M.; Olejnik, Orest; Whitcup, Scott M.; Burke, James A., Compositions and methods for localized therapy of the eye.
  52. Trogden, John T.; Salameh, Adnan K.; Pujara, Chetan P., Compositions and methods for stimulating hair growth.
  53. Magruder Paul R. (Palo Alto CA) Barclay Brian (Menlo Park CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA), Constant release system with pulsed release.
  54. Odidi, Isa; Odidi, Amina, Controlled extended drug release technology.
  55. Haslam John L. (Lawrence KS) Rork Gerald S. (Lawrence KS), Controlled porosity osmotic pump.
  56. Zentner Gaylen M. (Lawrence KS) Rork Gerald S. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA), Controlled porosity osmotic pump.
  57. Bull, Scott; Gupta, Suneel; Donley, Rhea; Modi, Nishit; Yam, Noymi, Controlled release compositions of tizanidine.
  58. Odidi, Isa; Odidi, Amina, Controlled release delivery device comprising an organosol coat.
  59. Odidi, Isa; Odidi, Amina, Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum.
  60. Odidi,Isa; Odidi,Amina, Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum.
  61. Wong Vernon G. ; Hu Mae W. L. ; Berger ; Jr. Donald E., Controlled-release biocompatible ocular drug delivery implant devices and methods.
  62. Eckenhoff ; deceased James B. (late of Los Altos CA by Bonnie J. Eckenhoff ; executrix ), Delivery device providing beneficial agent stability.
  63. Eckenhoff James B., Delivery device providing beneficial agent stability.
  64. Ayer Atul D. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA) Wong Patrick S. L. (Palo Alto CA) Hamel Lawrence G. (Sunnyvale CA) Jordan Maureen L. (Mt. View CA), Delivery dispenser for treating cardiac arrhythmias.
  65. Edgren David E. (El Granada CA) Theeuwes Felix (Los Altos CA), Delivery system.
  66. Magruder, Judy A.; Eckenhoff, James B.; Cortese, Richard; Wright, Jeremy C.; Peery, John R., Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement.
  67. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Delivery system comprising means for governing fluid into the system and for restricting fluid into the system.
  68. Magruder, Judy A.; Eckenhoff, James B.; Cortese, Richard; Wright, Jeremy C.; Peery, John R., Delivery system comprising two sections for delivering somatotropin.
  69. Eckenhoff James B. (Los Altos CA) Cortese Richard (San Jose CA) Landrau Felix A. (Milpitas CA), Delivery system controlled administration of beneficial agent to ruminants.
  70. Eckenhoff James B. (Los Altos CA) Magruder Judy A. (Mt. View CA) Cortese Richard (Cupertino CA) Peery John R. (Palo Alto CA) Wright Jeremy C. (Los Altos CA), Device comprising liner for protecting fluid sensitive medicament.
  71. Eckenhoff James B. (Los Altos CA) Magruder Judy A. (Mt. View CA) Cortese Richard (Cupertino CA) Peery John R. (Palo Alto CA) Wright Jeremy C. (Los Altos CA), Device comprising means for protecting and dispensing fluid sensitive medicament.
  72. Zentner Gaylen M. (Lawrence KS), Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins.
  73. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Device for the controlled delivery of a beneficial agent.
  74. Zentner Gaylen M. (Lawrence KS), Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins.
  75. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Dispenser comprising capsule with volume displacing member.
  76. Eckenhoff James B. (Los Altos) Cortese Richard (Los Gatos) Landrau Felix A. (Milpitas CA), Dispenser comprising hydrophilic osmopolymer.
  77. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Dispenser comprising inner and outer walls functioning as cooperative unit.
  78. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Dispenser comprising inner positioned soft or hard capsule.
  79. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Dispenser comprising telescopically engaging members.
  80. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Dispenser for delivering drug to livestock.
  81. Eckenhoff J. Benjamin (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters ; Joseph C. (Mountain View CA), Dispenser for delivering thermo-responsive composition.
  82. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Dispenser for increasing feed conversion of hog.
  83. Theeuwes Felix (Los Altos CA), Dispensing device with internal drive.
  84. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Dispensing system with means for increasing delivery of beneficial agent from the system.
  85. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Dispensing system with means for increasing delivery of beneficial agent from the system.
  86. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Dosage form and method for treating incontinence.
  87. Jao Frank ; Wong Patrick S. -L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Dosage form comprising antiepileptic drug.
  88. Dong Liang C. ; Dealey Michael H. ; Burkoth Terry L. ; Wong Patrick S. -L. ; Childers Jerry D. ; Barclay Brian L., Dosage form comprising hydrophilic polymer.
  89. Skluzacek, Robert R.; Edgren, David E., Dosage form comprising means for changing drug delivery shape.
  90. Barclay Brian L. (Sunnyvale CA) Wong Patrick S. L. (Palo Alto CA) Wright Jeri D. (Dublin CA) Childers Jerry D. (Fremont CA), Dosage form for administering nilvadipine for treating cardiovascular symptoms.
  91. Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA) Cortese Richard (Cupertino CA), Dosage form for delivering diltiazem.
  92. Ayer, Atul D.; Kuczynski, Anthony L.; Wong, Patrick S., Dosage form for delivering soluble or insoluble drugs.
  93. Magruder Paul R. (Palo Alto CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA) Guittard George V. (Cupertino CA), Dosage form for lessening irritation of mocusa.
  94. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases.
  95. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases.
  96. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases.
  97. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases comprising isradipine.
  98. Edgren David E. ; Skluzacek Robert R., Dosage form having first and second coats.
  99. Ayer Atul D. (Mountain View CA) Wong Patrick S. L. (Hayward CA), Dosage form with means for governing rate of gas formation.
  100. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Dosage system and method of using same.
  101. Benedetti, Hernan D.; Franco, Cristian R.; Bigatti, Guido S.; Faour, Joaquina; Pastini, Ana C., Dose-dumping resistant controlled release dosage form.
  102. Benedetti, Hernan D.; Franco, Cristian R.; Bigatti, Guido S.; Faour, Joaquina; Pastini, Ana C., Dose-dumping resistant controlled release dosage form.
  103. Benedetti, Hernan D.; Franco, Cristian R.; Bigatti, Guido S.; Faour, Joaquina; Pastini, Ana C., Dose-dumping resistant controlled release dosage form.
  104. Cruz, Evangeline; Ruhlmann, Gregory; Pollock, Brenda; Li, Sherry; Garcia, Carmelita; Wong, Alfredo M.; Bronz, Ryan; Fink, Tracy; Edgren, David, Drug coating providing high drug loading.
  105. Cruz, Evangeline; Ruhlmann, Gregory; Pollock, Brenda; Li, Sherry; Garcia, Carmelita; Wong, Alfredo M.; Bronz, Ryan; Fink, Tracy; Edgren, David, Drug coating providing high drug loading and methods for providing the same.
  106. Eckenhoff James B. (Los Altos CA) Theeuwes Felix (Los Altos CA) Deters Joseph C. (Mountain View CA), Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug.
  107. Jao Frank ; Wong Patrick S.-L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Effective therapy for epilepsies.
  108. Jao Frank ; Wong Patrick S.-L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Effective therapy for epilepsies.
  109. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  110. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  111. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  112. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  113. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  114. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  115. Edgren David Emil ; Skluzacek Robert Raymond ; Barclay Brian L. ; Bhatti Gurdish Kaur, Exit means in dosage form.
  116. Edgren David E. ; Li Shu ; Bhatti Gurdish Kaur ; Wong Patrick S. L. ; Skluzacek Robert R., Extended release dosage form.
  117. Edgren, David E.; Wong, Patrick S.-L.; Bhatti, Gurdish K.; Li, Shu; Skluzacek, Robert R., Extended release dosage form.
  118. Jain, Rita I.; Best, Andrea E.; Lockhart, Earle; Marx, Steven E.; Thomas, James W.; Vo, Pamela Giang, Extended release hydrocodone acetaminophen and related methods and uses thereof.
  119. Doud, Darren; Campbell, Randolph E.; Erickson, Signe; MacFarlane, K. Angela; Barrett, Mike; Skieller, Christina; Batten, David; Stine, Greg; de Juan, Jr., Eugene; Sutton, Douglas; Farinas, Kathleen Cogan, Fluid exchange apparatus and methods.
  120. Singh, Aniruddh; Mirmehrabi, Mahmoud, Forms of oxymorphone hydrochloride.
  121. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Fragmented hydrogels.
  122. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  123. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  124. Burson, Kim K.; Van Wyhe, Michelle; Pudlo, Jeffrey; Reidy, Michael; Soni, Pravin; Uhegbu, Christopher; Vijayakumar, Prema, Glucose measuring assembly with a hydrogel.
  125. Tamada,Janet A.; Tierney,Michael J.; Williams,Stephen C., Hydrogel composition for measuring glucose flux.
  126. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  127. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  128. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  129. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  130. Magruder Paul R. (Palo Alto CA) Wong Patrick S. (Hayward CA) Theeuwes Felix (Los Altos CA) Guittard George V. (Cupertino CA), Hydrogel formulation for administering non-steroidal drugs.
  131. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related implants.
  132. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  133. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  134. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  135. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  136. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  137. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  138. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  139. Hughes, Patrick M., Hypotensive prostamide-containing biodegradable intraocular implants and related methods.
  140. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  141. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  142. Rodstrom, Theron Robert, Implantable drug delivery system.
  143. Harper, Derek J.; Milo, Charles F., Implantable osmotic pump.
  144. Magruder Judy A. (Mt. View CA) Eckenhoff ; deceased James B. (late of Los Altos CA by Bonnie J. Eckenhoff ; executrix ) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (S, Implantable system for delivery of fluid-sensitive agents to animals.
  145. Magruder Judy A. ; Eckenhoff ; deceased James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R. ; Pike James B. ; Robinson Urano A. ; Smith Jonathan P. ; Ziemann Lyle E., Implantable system for delivery of fluid-sensitive agents to animals.
  146. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  147. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  148. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  149. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  150. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  151. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  152. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  153. Chitre, Kaustubh S.; Manesis, Nicholas J.; Trilokekar, Nikhil S.; Leslie, Dustin; Schuessler, David J., Inflatable prostheses and methods of making same.
  154. Chitre, Kaustubh S.; Manesis, Nicholas; Trilokekar, Nikhil S.; Leslie, Dustin; Schuessler, David J., Inflatable prostheses and methods of making same.
  155. Chou, Kang-Jye; Guo, Hong; Ashton, Paul; Shimizu, Robert W.; Watson, David A., Injectable sustained release delivery devices.
  156. Hill, David, Injectable tablet.
  157. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Doud, Darren; Erickson, Signe; Barrett, Mike; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  158. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Doud, Darren; Erickson, Signe; Barrett, Mike; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  159. de Juan, Jr., Eugene; Erickson, Signe; Campbell, Randolph E.; Doud, Darren; Barrett, Michael; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  160. de Juan, Jr., Eugene; Campbell, Randolph E.; Erickson, Signe; Barrett, Mike; Skieller, Christina; Batten, David; Doud, Darren, Insertion and removal methods and apparatus for therapeutic devices.
  161. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michele, Intraocular biodegradable microspheres.
  162. Robinson, Michael R.; Blanda, Wendy M.; Hughes, Patrick M.; Ruiz, Guadalupe; Orilla, Werhner C.; Whitcup, Scott M.; Welty, Devin F.; Lin, Joan-En; Spada, Lon T., Intraocular drug delivery systems.
  163. Hughes, Patrick M., Intraocular pressure reduction with intracameral bimatoprost implants.
  164. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Lamina comprising carboxyvinyl polymer.
  165. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Laminar arrangement for increasing delivery of beneficial agent from dispenser.
  166. Brögmann, Bianca; Muhlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  167. Brögmann, Bianca; Mühlah, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  168. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  169. Eckenhoff James B. (Los Altos CA), Means for providing instant agent from agent dispensing system.
  170. Leyendecker, Petra; Hopp, Michael; Drews, Axel, Method and device for the assessment of bowel function.
  171. Barclay Brian L. (Sunnyvale CA) Wong Patrick S. (Palo Alto CA) Wright Jeri D. (Dublin CA) Childers Jerry D. (Fremont CA), Method for administering nilvadipine for treating cardiovascular symptoms.
  172. Dong Liang C. ; Dealey Michael H. ; Burkoth Terry L. ; Wong Patrick S.-L. ; Childers Jerry D. ; Barclay Brian L., Method for administering steroid.
  173. Ayer Atul Devdatt ; Ridzon Dana A., Method for administering tandospirone.
  174. Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA) Cortese Richard (Cupertino CA), Method for delivering dosage form for diltiazem.
  175. Eckenhoff James B. (Los Altos CA) Magruder Judy A. (Mt. View CA) Cortese Richard (Cupertino CA) Peery John R. (Palo Alto CA) Wright Jeremy C. (Los Altos CA), Method for delivering somatotropin to an animal.
  176. Alberts Alfred W. (Princeton NJ) Scolnick Edward M. (Wyneewood PA) Repta Arnold J. (Lawrence KS), Method for enhancing the lowering of plasma cholesterol levels.
  177. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Method for establishing blood levels of biocide in animals.
  178. Anthony L. Kuczynski ; Atul Devolatt Ayer ; Patrick S. L. Wong, Method for lowering blood glucose.
  179. Kuczynski Anthony L. (Mountain View CA) Ayer Atul D. (Palo Alto CA) Wong Patrick S.-L. (Palo Alto CA), Method for lowering blood glucose.
  180. Kuczynski, Anthony L.; Ayer, Atul Devdatt; Wong, Patrick S. L., Method for lowering blood glucose.
  181. Dung, Jen-Sen; Keskeny, Erno M.; Mencel, James J., Method for making analgesics.
  182. Ayer Atul Devatt ; Yieh Richard L.-C. ; Pollock Brenda J. ; Wong Patrick S.-L., Method for providing sustained antiepileptic therapy.
  183. Wong, Vernon G, Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  184. Wong, Vernon G., Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  185. Wong, Vernon G., Method for reducing transplant rejection in the eye and intraocular implants for use therefor.
  186. Wong Patrick S.-L. (Palo Alto CA), Method for the management of hyperplasia.
  187. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Method for the management of incontinence.
  188. Ashton, Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  189. Jao Frank ; Wong Patrick S.-L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Method for treating epilepsies.
  190. David Emil Edgren ; Gurdish Kaur Bhatti ; Zahedeh Hatamkhani ; Patrick S. L. Wong, Method of administering antidepressant dosage form.
  191. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid.
  192. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michèle, Method of making tyrosine kinase microspheres.
  193. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  194. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  195. Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  196. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richar, Methods and devices for providing prolonged drug therapy.
  197. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richard G., Methods and devices for providing prolonged drug therapy.
  198. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Weyers, Richard G.; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Hatamkhany, Zah, Methods and devices for providing prolonged drug therapy.
  199. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D; Hatamkhany, Zahedeh; Weyers, Richard G; Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D., Methods and devices for providing prolonged drug therapy.
  200. Burson, Kim K.; Van Wyhe, Michelle; Pudlo, Jeffrey; Reidy, Michael; Soni, Pravin; Uhegbu, Christopher; Vijayakumar, Prema, Methods and devices for removing interfering species.
  201. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
  202. Wong, Vernon G., Methods for reducing edema.
  203. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use.
  204. Wong, Vernon G, Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  205. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  206. Wong,Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  207. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  208. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  209. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  210. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  211. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  212. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  213. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  214. Burson,Kim K.; Van Wyhe,Michelle; Pudlo,Jeffrey; Reidy,Michael; Soni,Pravin; Uhegbu,Christopher; Vijayakumar,Prema, Methods of manufacturing glucose measuring assemblies with hydrogels.
  215. Guido, Debora; Huang, Haiyong Hugh, Methods of preparing tamper resistant pharmaceutical formulations.
  216. Sackler, Richard S., Methods of preparing tamper resistant solid oral dosage forms.
  217. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Methods of treating ocular disease using steroid-containing sustained release intraocular implants.
  218. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Microparticles manufactured in an oil-in-water process comprising a prostamide.
  219. Schilder Lothar (Hamburg DEX) Dahlke Hermann (Hamburg DEX), Multi-layered implant.
  220. Faour,Joaquina; Mayorga,Jorge E., Multi-layered osmotic device.
  221. Zentner Gaylen M. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA) Rork Gerald S. (Lawrence KS), Multiparticulate controlled porosity osmotic.
  222. Haslam John L. (Lawrence KS) Rork Gerald S. (Lawrence KS), Multiparticulate controlled porosity osmotic pump.
  223. Weyers Richard G. ; Ayer Atul D. ; Pollock Brenda J. ; Barclay Brian L. ; Quan Ernest S., Nutritional support system.
  224. Weyers Richard G. ; Ayer Atul D. ; Pollock Brenda J. ; Barclay Brian L. ; Quan Ernest S., Nutritional support system.
  225. Bianchi, Keith; Hartsig, Bill; Nunn, Scott; Patel, Mukund; Sponsel, Mark; Vedrine, Lionel; Waitz, Ariel, Ocular implant delivery device and method.
  226. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  227. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  228. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  229. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  230. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  231. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  232. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  233. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and prostamide.
  234. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  235. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  236. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  237. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  238. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  239. Erickson, Signe; Campbell, Randolph E.; Doud, Darren, Ophthalmic implant for delivering therapeutic substances.
  240. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist / antagonist combinations.
  241. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  242. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  243. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  244. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  245. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  246. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist/antagonist combinations.
  247. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  248. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  249. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  250. Fleischer, Wolfgang; Reimer, Karen; Leyendecker, Petra, Opioids for the treatment of the chronic obstructive pulmonary disease (COPD).
  251. Wright, IV, Curtis; Carpanzano, Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  252. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  253. Kuczynski Anthony L. (Palo Alto CA) Ayer Atul D. (Palo Alto CA) Wong Patrick S.-L. (Palo Alto CA), Oral hypoglycemic glipizide granulation.
  254. Odidi, Isa; Odidi, Amina, Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors.
  255. Cundy, Kenneth C.; Gallop, Mark A., Orally administered dosage forms of GABA analog prodrugs having reduced toxicity.
  256. Ayer Atul D. (Mt. View CA), Osmotic device with inert core.
  257. Derek J. Harper ; Charles F. Milo, Osmotic pump delivery system with flexible drug compartment.
  258. Magruder Judy A. ; Eckenhoff James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R. ; Pike James B. ; Robinson Urano A. ; Smith Jonathan P. ; Ziemann Lyle E., Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals.
  259. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Oxybutynin therapy.
  260. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone compositions.
  261. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone.
  262. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone.
  263. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  264. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  265. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  266. Lyons, Robert T.; Robinson, Michael R.; Trogden, John T.; Whitcup, Scott M., Peripherally administered viscous formulations.
  267. Whitcup, Scott M.; Robinson, Michael R.; Lyons, Robert T.; Trogden, John T., Peripherally administered viscous formulations.
  268. Edgren,David E.; Li,Shu; Wong,Patrick S. L.; Bhatti,Gurdish; Dong,Liang Chang; Yum,Si Hong, Pharmaceutical coating composition and method of use.
  269. Edgren,David E.; Li,Shu; Wong,Patrick S. L.; Bhatti,Gurdish; Dong,Liang Chang; Yum,Si Hong, Pharmaceutical coating composition and method of use.
  270. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical composition containing gelling agent.
  271. Odidi, Isa; Odidi, Amina, Pharmaceutical composition having reduced abuse potential.
  272. Lyons, Robert T.; Chang, James N.; Trogden, John T.; Whitcup, Scott, Pharmaceutical compositions.
  273. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  274. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  275. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  276. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  277. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  278. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  279. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  280. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  281. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  282. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  283. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  284. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  285. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  286. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  287. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  288. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  289. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  290. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  291. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  292. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  293. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  294. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  295. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  296. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  297. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  298. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  299. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  300. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  301. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  302. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  303. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  304. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  305. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  306. Butler, Jackie; Devane, John; Stark, Paul, Pharmaceutical formulations for carrier-mediated transport statins and uses thereof.
  307. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  308. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  309. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical product comprising a sequestered agent.
  310. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical products.
  311. Shivanand Padmaja ; Hatamkhany Zahedeh ; Laidlaw Barbara F. ; Ayer Atul D., Phenytoin therapy.
  312. Theeuwes Felix (Los Altos CA), Plurality of tiny pills in liquid dosage form.
  313. Lee Jung-Chung ; Pushpala Shamim ; Lee Charles E., Polymeric microporous film coated subcutaneous implant.
  314. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Polysaccharide based hydrogels.
  315. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  316. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  317. Magruder Judy A. ; Eckenhoff James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R., Polyurethane-containing delivery systems.
  318. Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Farinas, Kathleen C., Posterior segment drug delivery.
  319. Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Farinas, Kathleen C., Posterior segment drug delivery.
  320. de Juan, Jr., Eugene; Alster, Yair; Chamow, Steven M.; Farinas, Kathleen Cogan; Giffor, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; George, Robert; Sutton, Douglas, Posterior segment drug delivery.
  321. de Juan, Jr., Eugene; Alster, Yair; Chamow, Steven M.; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; Macfarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; George, Robert; Sutton, Douglas, Posterior segment drug delivery.
  322. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  323. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  324. de Juan, Jr., Eugene; Alster, Yair; Gifford, III, Hanson S.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  325. Eckenhoff James B. (Los Altos CA), Process for forming dispensing device.
  326. Gebbie, Stuart James; Giguere, Joshua R.; McCarthy, Keith; Rider, Lonn S., Process for improved opioid synthesis.
  327. Giguere, Joshua Robert; McCarthy, Keith Edward; Schleusner, Marcel, Process for improved oxycodone synthesis.
  328. Giguere, Joshua Robert; McCarthy, Keith Edward; Schleusner, Marcel, Process for improved oxymorphone synthesis.
  329. Giguere, Joshua Robert; McCarthy, Keith Edward; Schleusner, Marcel, Process for improved oxymorphone synthesis.
  330. Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA), Process for manufacturing device with dispersion zone.
  331. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Process for preparing oxycodone compositions.
  332. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Process for preparing oxycodone compositions.
  333. Chapman,Robert; Rider,Lonn S.; Hong,Qi; Kyle,Donald; Kupper,Robert, Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  334. Wright Jeri D. (Dublin CA) Barclay Brian L. (Sunnyvale CA) Atkinson Linda E. (Portola Valley CA), Process for providing therapeutic composition.
  335. Grant, Ewart; Heinrich, Brian; Matharu, Saroop; Archer, Nicolas, Process for the preparation of oxymorphone alkaloid and oxymorphone salts.
  336. Matharu, Saroop; Heinrich, Brian; Singh, Aniruddh; Mirmehrabi, Mahmoud, Process of preparing low ABUK oxymorphone hydrochloride.
  337. Gallop, Mark A., Prodrugs of gaba analogs, compositions and uses thereof.
  338. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  339. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  340. Hamel Larry G. (Sunnyvale CA) Landrau Felix A. (Milpitas CA) Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA), Pseudoephedrine dosage form.
  341. Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA) Wong Patrick S. L. (Hayward CA), Pulsed drug delivery.
  342. Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA) Wong Patrick S. L. (Hayward CA), Pulsed drug delivery.
  343. Ayer Atul D. (Mountain View CA) Theeuwes Felix (Los Altos CA) Wong Patrick S. (Hayward CA), Pulsed drug delivery of doxylamine.
  344. Odidi, Isa; Odidi, Amina, Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems.
  345. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Rate controlled dispenser for administering beneficial agent.
  346. Varner, Signe Erickson; De Juan, Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  347. Varner, Signe Erickson; Dejuan, Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  348. Varner, Signe Erickson; de Juan, Jr., Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  349. Eckenhoff James B. (Los Altos CA), Ruminant dispensing device.
  350. Eckenhoff James B. (Los Altos CA), Ruminant dispensing device.
  351. Eckenhoff James B. (Los Altos CA), Ruminant dispensing device comprising agent displacement member.
  352. Eckenhoff James B. (Los Altos CA), Ruminant dispensing device with thermo-activated memory.
  353. Cink,Russell Drew; Paterson, Jr.,Joseph B.; Gao,Yi; Zhang,Geoff G. Z.; Long,Michelle A.; Morris,John B.; Rosenberg,Joerg, Salts of fenofibric acid and pharmaceutical formulations thereof.
  354. Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Landrau Felix A. (Milpitas CA), Self controlled release device for administering beneficial agent to recipient.
  355. Schuessler, David, Self-sealing shell for inflatable prostheses.
  356. Schuessler, David J., Self-sealing shell for inflatable prostheses.
  357. Schuessler, David J., Self-sealing shell for inflatable prostheses.
  358. Schuessler, David J., Self-sealing shell for inflatable prostheses.
  359. Schuessler, David J., Self-sealing shell for inflatable prostheses.
  360. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  361. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  362. Berner, Bret; Louie-Helm, Jenny; Gusler, Gloria; Shell, John N., Shell and core dosage form approaching zero-order drug release.
  363. Berner, Bret; Louie-Helm, Jenny; Gusler, Gloria; Shell, John N., Shell-and-core dosage form approaching zero-order drug release.
  364. Berner, Bret; Louie-Helm, Jenny; Shell, John N., Shell-and-core dosage form approaching zero-order drug release.
  365. De Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Erickson, Signe, Small molecule delivery with implantable therapeutic device.
  366. Zentner Gaylen M. (Lawrence KS) McClelland Gregory A. (Lenexa KS), Solubility modulated drug delivery device.
  367. Horvath, Judit; Astafieva, Irina; Erickson, Signe; Farinas, Kathleen Cogan, Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof.
  368. Horvath, Judit; Astafieva, Irina; Erickson, Signe; Farinas, Kathleen Cogan, Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof.
  369. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  370. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  371. Robinson, Michael R.; Whitcup, Scott M., Steroid-containing sustained release intraocular implants and related methods.
  372. Ayer Atul Devatt ; Yien Richard L.-C. ; Pollock Brenda J. ; Wong Patrick S.-L., Sustained antiepileptic therapy.
  373. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  374. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  375. Mazer Terrence B. ; Walton Joseph E. ; Arnholt Barbara S. ; Evans Monty L. ; Geckle Ronita K. ; Hamilton Daniel ; Kropczynski ; Jr. John J. ; Murawski Frank A. ; Tucker Larry G. ; Walker Sherri A. ; , Sustained release dosage form unit having latex coating and method of making the same.
  376. Mazer, Terrence B.; Walton, Joseph E.; Arnholt, Barbara S.; Evans, Monty L.; Geckle, Ronita K.; Hamilton, Daniel; Kropczynski, Jr., John J.; Murawski, Frank A.; Tucker, Larry G.; Walker, Sherri A.; W, Sustained release dosage form unit having latex coating and method of making the same.
  377. Chen Jianbing ; Ashton Paul, Sustained release drug delivery devices.
  378. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  379. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  380. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  381. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  382. Hong Guo ; Paul Ashton, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  383. Qiu, Yihong; Klein, Cheri E, Sustained release formulations of opioid and nonopioid analgesics.
  384. Burke, James; Hughes, Patrick M.; Werhner, Orilla C.; Lin, Ton C.; Escobar, Maria; Huang, Glenn; Zhang, Kai-Ming; Wheeler, Larry A.; Donn, Rosy S., Sustained release intraocular implants and methods for preventing retinal dysfunction.
  385. Huang, Glenn T.; Burke, James A.; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Sheng, Rosy, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  386. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  387. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  388. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and methods for treating ocular neuropathies.
  389. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  390. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  391. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  392. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  393. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  394. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  395. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  396. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  397. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  398. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  399. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  400. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffrey L.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  401. Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Edelman, Jeffrey L.; Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  402. Jao, Frank; Wong, Patrick S. -L.; Huynh, Hoa T.; Mc Chesney, Kathy; Wat, Pamela K., System for delaying drug delivery up to seven hours.
  403. Astafieva, Irina; Horvath, Judit; Farinas, Kathleen Cogan; Bueche, Blaine; Erickson, Signe, Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant.
  404. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  405. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  406. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  407. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  408. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  409. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  410. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  411. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  412. Sackler, Richard S., Tamper resistant solid oral dosage forms.
  413. Bonutti, Peter M., Therapeutic system.
  414. Ernst Amy A., Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use.
  415. Ernst Amy A. (26 Maryland Dr. New Orleans LA 70124), Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use.
  416. Barrett, Ronald W.; Canafax, Daniel M., Treating or preventing restless legs syndrome using prodrugs of GABA analogs.
  417. Barrett, Ronald W., Treating urinary incontinence using prodrugs of GABA analogs.
  418. Eckenhoff James B. (Los Altos CA), Veterinary dispenser delivering beneficial agent by gas power generated in situ.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로